Evidence map›Paper›PMID 40615189›Full record

ArticleJACC. Case reports2025

Cardiac Sarcoidosis and Troponin T-Related Cardiomyopathy.

Alec Chu Ming Yu, Anto Sedlic, Harmanjot Singh, Kathryn Darras, Brian Clarke, Thomas M Roston

Abstract readCase Reports
In one paragraph

Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alec Chu Ming YuDepartment of Medicine, University of British Columbia, Vancouver, Canada.
Anto SedlicDepartment of Radiology, University of British Columbia, Vancouver, Canada.
Harmanjot SinghDepartment of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada.
Kathryn DarrasDepartment of Nuclear Medicine, University of British Columbia, Vancouver, Canada.
Brian ClarkeDivision of Cardiology and Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, Canada.
Thomas M RostonDivision of Cardiology and Centre for Cardiovascular Innovation, University of British Columbia, Vancouver, Canada. Electronic address: rostontm@alumni.ubc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiac sarcoidosis and genetic cardiomyopathy are both rare causes of heart disease with often similar presentations that can be difficult to diagnose. CASE SUMMARY: We describe a previously healthy 43-year-old woman with progressive cardiomyopathy despite thorough investigation and several trials of therapy. She was eventually diagnosed with both cardiac sarcoidosis and a familial cardiac troponin type 2 (TNNT2) variant encoding cardiac troponin type 2. DISCUSSION: Previous studies demonstrate that a proportion of patients diagnosed with isolated cardiac sarcoidosis or idiopathic myocarditis have pathogenic variants linked to genetic cardiomyopathy. Our case highlights the challenging journey of a patient who was eventually found to have both sarcoidosis and genetic cardiomyopathy, and we discuss relevant principles in diagnosing and managing these concurrent pathologies.

Indexed as

cardiac sarcoidosisgenetic cardiomyopathyinherited cardiomyopathy

Identifiers

PMID40615189
PMCPMC12441445

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.